Pharma Solutions
Overview
Cardio Metabolic
MASLD/MASH
Autoimmune Disease
Gastrointestinal Disease
Oncology
Clinical Solutions
LiverMultiScan
MRCP+
CoverScan
Hepatica
Perspectum Portal
Research
Overview
Publications
Research Projects
Research Network
company
Overview
Senior Management
Board of Directors
Company News
Careers
Events
Webinars
Media Center
OUR LOCATIONS
< RETURN TO RESEARCHERS
Publications
Atlas
CoverScan
Digipath
Hepatica
LiverMultiScan
MRCP+
Pathology Solutions
Pharma Solutions
AILD
Autoimmun hepatitits (AIH)
Autoimmune liver disease (AILD)
Autoimmune sclerosis cholangitis (ASC)
Biliary disease
COVID-19
Cardiac lipid accumulation
Cholestatic liver disease
Chronic liver disease
Colorectal liver metastases
Diastolic dysfunction
Diffuse liver disease
Focal liver disease
Genetic sequencing
Haemochromatosis
Hemochromatosis
Hepatic steatosis
Hepatitis C virus (HCV)
Hepatobiliary disease
Hepatocellular carcinoma (HCC)
Iron overload
LV hypertrophy
Liver cancer
Long COVID
Muti-organ impairment
Myocardial steatosis
NAFLD/NASH
Pancreatic cancer
Pancreatic fat
Pancreatitis
Portal hypertension
Primary biliary cholangitis (PBC)
Primary sclerosing cholangitis (PSC)
SARS-COV2
Type 2 diabetes (T2DM)
UK Biobank
Wilson disease
Filter by disease type
Any
Filter by product
Any
Search:
placeholder
clear filter
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
[Poster] The “IDEAL” method for fat quantification and iron-corrected T1 accurately measure the presence and severity of the individual histological features of nonalcoholic steatohepatitis (NASH)
Author:
Siddiqui, M., Grawenda, A., Cadrain, R., Collen, R., Steinberg, J., Luketic, V., Dennis, A., Hildick, K., Kelly, M.D., Neubauer, S., Banerjee, R., and Sanyal, A.
Journal:
Hepatology
Publication Year:
2018
Volume/Issue:
68(1)
Pages:
1322 Abstract 2338
Aldon.knolls@perspectum.com
Author:
Henry Wilman, Velicia Bachtiar, Jaco Jacobs, Rex Newbould, Michael Gyngell, Cat Kelly, Matt Kelly, Stefan Neubauer, Rajarshi Banerjee.
Journal:
Journal of Hepatology
Publication Year:
2018
Volume/Issue:
Volume 68, Supplement 1
Pages:
S562, Abstract: FRI-443
Measurement of liver iron by magnetic resonance imaging in the UK Biobank population
Author:
McKay, A., Wilman, H. R., Dennis, A., Kelly, M., Gyngell, M. L., Neubauer, S., Bell, J. D., Banerjee, R., & Thomas, E. L.
Journal:
PLOS ONE
Publication Year:
2018
Volume/Issue:
13(12)
Pages:
e0209340
Reference range of liver corrected T1 values in a population at low risk for fatty liver disease—a UK Biobank sub-study, with an appendix of interesting cases
Author:
Mojtahed, A., Kelly, C. J., Herlihy, A. H., Kin, S., Wilman, H. R., McKay, A., Kelly, M., Milanesi, M., Neubauer, S., Thomas, E. L., Bell, J. D., Banerjee, R., & Harisinghani, M.
Journal:
Abdominal Radiology
Publication Year:
2019
Volume/Issue:
44(1)
Pages:
72-84
1
...
14 / 27
Digipath
Atlas
Pharma Solutions
CoverScan
Hepatica
LiverMultiScan
Pathology Solutions
MRCP+
UK Biobank
Pancreatitis
Pancreatic cancer
Wilson disease
Cardiac lipid accumulation
Diastolic dysfunction
LV hypertrophy
Myocardial steatosis
Portal hypertension
Iron overload
Haemochromatosis
Hemochromatosis
Hepatobiliary disease
Primary biliary cholangitis (PBC)
Type 2 diabetes (T2DM)
Diffuse liver disease
Cholestatic liver disease
Hepatitis C virus (HCV)
SARS-COV2
Long COVID
Pancreatic fat
Muti-organ impairment
COVID-19
Hepatic steatosis
Chronic liver disease
Hepatocellular carcinoma (HCC)
Colorectal liver metastases
Focal liver disease
Liver cancer
Primary sclerosing cholangitis (PSC)
Biliary disease
Genetic sequencing
NAFLD/NASH
Autoimmune sclerosis cholangitis (ASC)
Autoimmune liver disease (AILD)
Autoimmun hepatitits (AIH)
AILD